Clinical Rater
Brooklyn Health
Clinical Rater
Brooklyn Health
AI-driven eCOA platform for CNS trials
About Brooklyn Health
Brooklyn Health is solving the measurement problem in mental health through accurate, objective, and sensitive measurement of symptoms, enabling precision neuroscience in clinical research and patient care. The company’s Willis platform is modernizing the technology stack for CNS clinical trials, improving endpoint quality and reducing placebo response. Brooklyn Health is backed by leading healthcare and technology investors including HealthX Ventures, Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures and others. For more information, visit www.brooklyn.health.
About the role
We’re hiring Clinical Raters and Senior Clinical Raters to oversee the integrity and reliability of endpoint data collected during study visits in CNS clinical trials. Clinical Raters and Senior Clinical Raters sit within the Clinical Science team.
Responsibilities
Perform manual, independent reviews of recorded clinical trial interviews and scale administrations to ensure scoring accuracy, interview quality, and protocol adherence.
Maintain clear, reproducible documentation of review findings, scoring justifications, and site intervention plans aligned with protocol expectations.
Senior Clinical Raters only: Participate in clinical decision-making regarding site performance, evaluate and provide interpretation for rater patterns, and directly oversee targeted site interventions and rater remediation.
Requirements
5+ years experience as a Clinical Rater, Central Rater, or Secondary Reviewer on CNS clinical trials (e.g., Psychiatry, Neurology).
Meticulous attention to detail with a strong background in clinical data evaluation, quality control frameworks, or trial QA workflows.
Demonstrated ability to interpret rater performance data, guide clinical decision-making, and manage site-facing interventions constructively.
AI-driven eCOA platform for CNS trials
Brooklyn Health builds Willis, an electronic Clinical Outcome Assessment (eCOA) platform for CNS clinical trials that uses AI and digital phenotyping to derive objective measurements from clinical interviews by analyzing spoken words, facial expressions, body language, and voice tone. The platform is organized into OpenWillis (an open-source library of digital phenotyping methods), WillisPipeline (which converts behavioral data into clinical measures), and WillisAPI (for integrating with other digital health tools). It differentiates itself by providing validated, standardized digital measures that reduce bias and help distinguish drug effects from placebo in trials conducted with major pharma partners like Bristol Myers Squibb and Boehringer Ingelheim. Brooklyn Health’s goal is to improve the accuracy of treatment evaluation in CNS trials and lower failure rates in CNS drug development.
Explore more opportunities at Brooklyn Health